Intra-Cellular Therapies, Inc.
USD131.87
+0.00 (+0.00%)
CEO
Sharon Mates
IPO Date
2014-01-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$131.87
Prev. Close
$131.87
Day Low
$131.87
Day High
$131.87
52W Low
$64.09
52W High
$131.98
Market Cap
$14.05B
Volume
16.04M
| -49.2 |
| 31 Dec 2022 | FY | 91.8% | -102.9% | -39.1% | -34.0% | 0.03 | 8.87 | -19.4 |
| 31 Dec 2021 | FY | 90.2% | -347.7% | -68.0% | -58.0% | 44.75 | 8.76 | -15.0 |
| 31 Dec 2020 | FY | 91.6% | -1007.5% | -34.6% | -31.6% | 0.04 | 18.75 | -9.9 |
| 31 Dec 2019 | FY | -687.2% | -243713.7% | -75.8% | -58.8% | 0.12 | 6.36 | -12.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -48.8% | -43.4% | 0.00 | 9.79 | -4.0 |
| 31 Dec 2017 | FY | -32205.6% | -39771.6% | -21.5% | -20.7% | 0.00 | 33.02 | -6.8 |
| 31 Dec 2016 | FY | -28273.4% | -35205.8% | -31.0% | -29.9% | 0.00 | 36.86 | -5.6 |
| 31 Dec 2015 | FY | -52.8% | -114698.5% | -22.0% | -21.6% | 0.00 | 77.15 | -18.5 |
| -73.5 |
| 30 Jun 2024 | Q2 | 93.0% | -10.1% | -1.4% | -1.2% | 0.02 | 7.81 | -108.7 |
| 31 Mar 2024 | Q1 | 93.2% | -10.5% | -2.5% | -2.0% | 0.03 | 5.12 | -108.4 |
| 31 Dec 2023 | Q4 | 91.9% | -21.7% | -4.8% | -3.9% | 0.03 | 5.41 | -60.3 |
| 30 Sept 2023 | Q3 | 92.7% | -19.3% | -4.0% | -3.4% | 0.03 | 6.81 | -51.6 |
| 30 Jun 2023 | Q2 | 93.5% | -38.8% | -7.0% | -6.0% | 0.03 | 7.58 | -35.5 |
| 31 Mar 2023 | Q1 | 92.9% | -46.5% | -7.0% | -6.1% | 0.03 | 8.87 | -29.2 |
| 31 Dec 2022 | Q4 | 92.2% | -42.6% | -5.7% | -4.9% | 0.03 | 8.87 | -33.6 |
| 30 Sept 2022 | Q3 | 91.9% | -74.5% | -7.8% | -6.8% | 0.04 | 9.81 | -20.4 |